Filing Details
- Accession Number:
- 0000899243-16-025823
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-07-28 18:01:04
- Reporting Period:
- 2016-07-27
- Filing Date:
- 2016-07-28
- Accepted Time:
- 2016-07-28 18:01:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609809 | Seres Therapeutics Inc. | MCRB | Pharmaceutical Preparations (2834) | 274326290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614936 | Roger Pomerantz | C/O Seres Therapeutics, Inc. 200 Sidney Street Cambridge MA 02139 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-07-27 | 20,000 | $0.71 | 203,692 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-07-27 | 20,000 | $35.00 | 183,692 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2016-07-27 | 20,000 | $0.00 | 20,000 | $0.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,052,286 | 2024-08-07 | No | 4 | M | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person on February 26, 2016.
- The option vested as to 25% of the shares subject to the option on June 1, 2015. The remainder of the shares have vested or will vest in 12 equal quarterly installments thereafter.
- Includes 3 shares omitted from the reporting persons prior Form 4 filed on July 7, 2016 due to an administrative error.
Billionaire Hedge Funds
